These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26876561)

  • 21. Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study.
    Kondo Y; Satoh S; Osada UN; Terauchi Y
    Endocr J; 2015; 62(11):971-80. PubMed ID: 26249841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model.
    Plesner A; Soukhatcheva G; Korneluk RG; Verchere CB
    Islets; 2010; 2(1):18-23. PubMed ID: 21099289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liraglutide in diabetes mellitus: More facts and findings.
    Rahman IU; Idrees M; Bashir M; Khan MI; Jan NU; Rahim H
    Pak J Pharm Sci; 2016 Mar; 29(2):609-13. PubMed ID: 27087083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
    J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.
    Anholm C; Kumarathurai P; Pedersen LR; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
    Diabetes Obes Metab; 2017 Jun; 19(6):850-857. PubMed ID: 28124822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidiabetogenic efficiency of menthol, improves glucose homeostasis and attenuates pancreatic β-cell apoptosis in streptozotocin-nicotinamide induced experimental rats through ameliorating glucose metabolic enzymes.
    Muruganathan U; Srinivasan S; Vinothkumar V
    Biomed Pharmacother; 2017 Aug; 92():229-239. PubMed ID: 28549291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus.
    Mansur SA; Mieczkowska A; Bouvard B; Flatt PR; Chappard D; Irwin N; Mabilleau G
    J Cell Physiol; 2015 Dec; 230(12):3009-18. PubMed ID: 26016732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function.
    Morita A; Mukai E; Hiratsuka A; Takatani T; Iwanaga T; Lee EY; Miki T
    Endocrine; 2016 Mar; 51(3):429-39. PubMed ID: 26349938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin mimetics and DPP-4 inhibitors: new approach to treatment of type 2 diabetes mellitus.
    Siddiqui NI
    Mymensingh Med J; 2009 Jan; 18(1):113-24. PubMed ID: 19182763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
    Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
    Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
    Remedi MS; Nichols CG
    PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes.
    Villalba A; Rodriguez-Fernandez S; Perna-Barrull D; Ampudia RM; Gomez-Muñoz L; Pujol-Autonell I; Aguilera E; Risueño RM; Cano-Sarabia M; Maspoch D; Vázquez F; Vives-Pi M
    Sci Rep; 2020 Nov; 10(1):18927. PubMed ID: 33144616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation GLP-1 therapy: an introduction to liraglutide.
    Repas T
    Postgrad Med; 2011 Sep; 123(5):239-47. PubMed ID: 21904107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of non-peptide glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes.
    Moon HS; Kim MK; Son MH
    Arch Pharm Res; 2011 Jul; 34(7):1041-3. PubMed ID: 21811909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapies for the treatment of type 2 diabetes mellitus based on incretin action.
    Gallwitz B
    Minerva Endocrinol; 2006 Jun; 31(2):133-47. PubMed ID: 16682937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial Effects of Small Molecule Oligopeptides Isolated from Panax ginseng Meyer on Pancreatic Beta-Cell Dysfunction and Death in Diabetic Rats.
    Xu M; Sun B; Li D; Mao R; Li H; Li Y; Wang J
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28954411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice.
    Dalbøge LS; Almholt DL; Neerup TS; Vrang N; Jelsing J; Fosgerau K
    J Pharmacol Exp Ther; 2014 Aug; 350(2):353-60. PubMed ID: 24902584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
    Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
    Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of epoxypukalide on pancreatic β-cells and glucose metabolism in STZ-induced diabetic mice.
    López-Acosta JF; Villa-Pérez P; Fernández-Díaz CM; Román Dde L; Díaz-Marrero AR; Cueto M; Perdomo G; Cózar-Castellano I
    Islets; 2015; 7(2):e1078053. PubMed ID: 26406478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.